{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:55:31Z","timestamp":1761216931202},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T00:00:00Z","timestamp":1129852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/sj.cdd.4401783","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T11:44:21Z","timestamp":1129895061000},"page":"642-651","source":"Crossref","is-referenced-by-count":9,"title":["Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells"],"prefix":"10.1038","volume":"13","author":[{"given":"S","family":"Amos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G T","family":"Redpath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Polar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"McPheson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I M","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,21]]},"reference":[{"key":"BF4401783_CR1","volume-title":"Tumours of the Nervous System: Pathology and Genetics","author":"P Kleiheus","year":"2000","unstructured":"Kleiheus P and Caveness WK (2000) Tumours of the Nervous System: Pathology and Genetics Lyon: International Agency for Research on Cancer"},{"key":"BF4401783_CR2","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","volume":"90","author":"JG Cairncross","year":"1998","unstructured":"Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA and Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 90: 1473\u20131479","journal-title":"J. Natl. Cancer Inst."},{"key":"BF4401783_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","volume":"18","author":"JS Smith","year":"2000","unstructured":"Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW and Jenkins RB (2000) Alteration of 1p and 19q as predictors of survival in oligodendrogliomas. J. Clin. Oncol. 18: 636\u2013645","journal-title":"J. Clin. Oncol."},{"key":"BF4401783_CR4","first-page":"2387","volume":"7","author":"A Chakravarti","year":"2001","unstructured":"Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A and Dyson NJ (2001) Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin. Cancer Res. 7: 2387\u20132395","journal-title":"Clin. Cancer Res."},{"key":"BF4401783_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1101\/gad.891601","volume":"15","author":"EA Maher","year":"2001","unstructured":"Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15: 1311\u20131333","journal-title":"Genes Dev."},{"key":"BF4401783_CR6","first-page":"1","volume":"8","author":"S Krishnan","year":"2003","unstructured":"Krishnan S, Rao RD, James CD and Sarkaria JN (2003) Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas. Front Biosci. 8: 1\u201313","journal-title":"Front Biosci."},{"key":"BF4401783_CR7","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1074\/jbc.M108302200","volume":"277","author":"LD Mayo","year":"2002","unstructured":"Mayo LD, Dixon JE, Durden DL, Tonks NK and Donner DB (2002) PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277: 5484\u20135489","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3171\/jns.1999.91.6.0997","volume":"91","author":"WC Broaddus","year":"1999","unstructured":"Broaddus WC, Liu Y, Steele LL, Gillies GT, Lin PS, Loudon WG, Valerie K, Schmidt-Ullrich RK and Fillmore HL. (1999) Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction. J. Neurosurg. 91: 997\u20131004","journal-title":"J. Neurosurg."},{"key":"BF4401783_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/neuonc\/4.1.9","volume":"4","author":"IM Hussaini","year":"2002","unstructured":"Hussaini IM, Sando JJ, Carpenter JE, Redpath GT, Shaffrey ME and VandenBerg SR (2002) Protein kinase C-\u03b7 regulates resistance to UV- and \u03b3-irradiation-induced apoptosis by preventing caspase-9 cleavage in astrocytomas. Neuro-Oncology 4: 9\u201313","journal-title":"Neuro-Oncology"},{"key":"BF4401783_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1750-3639.2003.tb00006.x","volume":"13","author":"PS Mischel","year":"2003","unstructured":"Mischel PS and Cloughesy TF (2003) Targeted molecular therapy of GBM. Brain Pathol. 13: 52\u201361","journal-title":"Brain Pathol."},{"key":"BF4401783_CR11","first-page":"4307","volume":"62","author":"A Chakravarti","year":"2002","unstructured":"Chakravarti A, Chakladar A, Delaney MA, Latham DE and Loeffler JS (2002) The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res. 62: 4307\u20134315","journal-title":"Cancer Res."},{"key":"BF4401783_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/scdb.2000.0181","volume":"11","author":"JA Mercer","year":"2000","unstructured":"Mercer JA (2000) Intercellular junctions: downstream and upstream of Ras? Semin. Cell Dev. Biol. 11: 309\u2013314","journal-title":"Semin. Cell Dev. Biol."},{"key":"BF4401783_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/sj.onc.1201354","volume":"15","author":"S Pells","year":"1997","unstructured":"Pells S, Divjak M, Romanowski P, Impey H, Hawkins NJ, Clarke AR, Hooper ML and Williamson DJ (1997) Developmentally-regulated expression of murine K-ras isoforms. Oncogene. 15: 1781\u20131786","journal-title":"Oncogene."},{"key":"BF4401783_CR14","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1074\/jbc.271.10.5871","volume":"271","author":"E Porfiri","year":"1996","unstructured":"Porfiri E and McCormick F (1996) Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1. J. Biol. Chem. 271: 5871\u20135877","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR15","first-page":"5879","volume":"60","author":"A Maity","year":"2000","unstructured":"Maity A, Pore N, Lee J, Solomon D and O'Rourke DM (2000) Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3\u2032-kinase and distinct from that induced by hypoxia. Cancer Res. 60: 5879\u20135886","journal-title":"Cancer Res."},{"key":"BF4401783_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0165-6147(97)90677-5","volume":"11","author":"CA Omer","year":"1997","unstructured":"Omer CA and Kohl NE (1997) CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents. Trends Pharmacol. Sci. 11: 437\u2013444","journal-title":"Trends Pharmacol. Sci."},{"key":"BF4401783_CR17","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1126\/science.275.5307.1750","volume":"275","author":"MH Gelb","year":"1997","unstructured":"Gelb MH (1997) Protein prenylation, et cetera: signal transduction in two dimensions. Science. 275: 1750\u20131751","journal-title":"Science."},{"key":"BF4401783_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-642-78267-1_22","volume-title":"GTPases in Biology","author":"JB Gribbs","year":"1993","unstructured":"Gribbs JB (1993) Lipid modification of proteins in the Ras superfamily In: GTPases in Biology Birnbaumer L, Dickey B (eds). New York NY: springer-Verlag, pp 335\u2013344"},{"key":"BF4401783_CR19","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1074\/jbc.272.15.10232","volume":"272","author":"FL Zhang","year":"1997","unstructured":"Zhang FL, Kirschmeier P, Carr D, James L, Bond RW, Wang L, Patton R, Windsor WT, Syto R, Zhang R and Bishop WR (1997) Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J. Biol. Chem. 272: 10232\u201313239","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR20","doi-asserted-by":"publisher","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","volume":"272","author":"DB Whyte","year":"1997","unstructured":"Whyte DB, Kirschmeier P, Hockenberry TN, Nunez-Oliva I, James L, Catino JJ, Bishop WR and Pai JK (1997) K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. Biol. Chem. 272: 14459\u201314464","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR21","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.onc.1201656","volume":"16","author":"J Sun","year":"1998","unstructured":"Sun J, Qian Y, Hamilton AD and Sebti SM (1998) Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene 16: 1467\u20131473","journal-title":"Oncogene"},{"key":"BF4401783_CR22","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.1038\/sj.onc.1204950","volume":"20","author":"A Paz","year":"2001","unstructured":"Paz A, Haklai R, Elad-Sfadia G, Ballan E and Kloog Y (2001) Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20: 7486\u20137493","journal-title":"Oncogene"},{"key":"BF4401783_CR23","first-page":"5656","volume":"63","author":"TB Brunner","year":"2003","unstructured":"Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG and Bernhard EJ (2003) Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. Cancer Res 63: 5656\u20135668","journal-title":"Cancer Res"},{"key":"BF4401783_CR24","doi-asserted-by":"publisher","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","volume":"270","author":"M Marom","year":"1995","unstructured":"Marom M, Haklai R, Ben-Baruch G, Marciano D, Egozi Y and Kloog Y. (1995) Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid. J. Biol. Chem. 270: 22263\u201322270","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/neuonc\/1.2.124","volume":"1","author":"M Nozaki","year":"1999","unstructured":"Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N and Van Meir EG (1999) Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neuro-oncology 1: 124\u2013137","journal-title":"Neuro-oncology"},{"issue":"12","key":"BF4401783_CR26","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1074\/jbc.271.12.6794","volume":"271","author":"C Herrmann","year":"1996","unstructured":"Herrmann C, Horn G, Spaargaren M and Wittinghofer A (1996) Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 271 (12): 6794\u20136800","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR27","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta SR, Brunet A and Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev. 13: 2905\u20132927","journal-title":"Genes Dev."},{"key":"BF4401783_CR28","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","volume":"270","author":"Z Xia","year":"1995","unstructured":"Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326\u20131331","journal-title":"Science"},{"key":"BF4401783_CR29","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1128\/MCB.19.8.5308","volume":"19","author":"P Erhardt","year":"1999","unstructured":"Erhardt P, Schremser EJ and Cooper GM (1999) B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK\/Erk pathway. Mol. Cell. Biol. 19: 5308\u20135315","journal-title":"Mol. Cell. Biol."},{"key":"BF4401783_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1091\/mbc.11.3.1103","volume":"11","author":"M Le Gall","year":"2000","unstructured":"Le Gall M, Chambard JC, Breittmayer JP, Grall D, Pouyssegur J and Van Obberghen-Schilling E (2000) The p42\/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 11: 1103\u20131112","journal-title":"Mol. Biol. Cell"},{"key":"BF4401783_CR31","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1128\/MCB.21.7.2324-2336.2001","volume":"21","author":"A von Gise","year":"2001","unstructured":"von Gise A, Lorenz P, Wellbrock C, Hemmings B, Berberich-Siebelt F, Rapp UR and Troppmair J (2001) Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals. Mol. Cell. Biol. 21: 2324\u20132336","journal-title":"Mol. Cell. Biol."},{"key":"BF4401783_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb1005","volume":"5","author":"LA Allan","year":"2003","unstructured":"Allan LA, Morrice N, Brady S Magee G, Pathak S and Clarke PR (2003) Inhibition of caspase-9 through phosphorylation at thr125 by ERK MAPK. Nature Cell Biol. 5: 647\u2013654","journal-title":"Nature Cell Biol."},{"key":"BF4401783_CR33","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1021\/bi972032d","volume":"37","author":"R Haklai","year":"1998","unstructured":"Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G and Kloog Y (1998) Dislodgment and accelerated degradation of Ras. Biochemistry 37: 1306\u20131314","journal-title":"Biochemistry"},{"issue":"16","key":"BF4401783_CR34","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1038\/sj.onc.1202602","volume":"18","author":"B Weisz","year":"1999","unstructured":"Weisz B, Giehl K, Gana-Weisz M, Egozi Y, Ben-Baruch G, Marciano D and Gierschik P and Kloog Y (1999) A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice. Oncogene 18 (16): 2579\u20132588","journal-title":"Oncogene"},{"key":"BF4401783_CR35","doi-asserted-by":"publisher","first-page":"14019","DOI":"10.1073\/pnas.96.24.14019","volume":"96","author":"B Jansen","year":"1999","unstructured":"Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer BX, Eichler H, Pehamberger H, Gana-Weisz M, Ben-David E, Kloog Y and Wolff K (1999) Novel Ras antagonist blocks human melanoma growth. Proc. Natl. Acad. Sci. USA 96: 14019\u201314024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF4401783_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.bi.61.070192.002035","volume":"61","author":"S Clarke","year":"1992","unstructured":"Clarke S (1992) Protein Isoprenylation and methylation at carboxy-terminal cystein residues. Annu. Rev. Biochem. 61: 355\u2013386","journal-title":"Annu. Rev. Biochem."},{"key":"BF4401783_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ijc.10213","volume":"98","author":"KSM Smalley","year":"2002","unstructured":"Smalley KSM and Eisen TG (2002) Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. Int. J. Cancer 98: 514\u2013522","journal-title":"Int. J. Cancer"},{"key":"BF4401783_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/pros.10336","volume":"58","author":"RA McPherson","year":"2004","unstructured":"McPherson RA, Conaway MC, Gregory CW, Yue W and Santen RJ (2004) The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro. Prostate 58: 325\u2013334","journal-title":"Prostate"},{"key":"BF4401783_CR39","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1200\/JCO.1999.17.11.3631","volume":"17","author":"EK Rowinsky","year":"1999","unstructured":"Rowinsky EK, Windle JJ and Von Hoff DD (1999) Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development. J. Clin. Oncol. 17: 3631\u20133652","journal-title":"J. Clin. Oncol."},{"key":"BF4401783_CR40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.999.65.3","volume":"65","author":"R Blum","year":"2005","unstructured":"Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G and Kloog Y (2005) Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1\u03b1, causing glycolysis shutdown and cell death. Cancer. Res. 65: 999\u20131006","journal-title":"Cancer. Res."},{"key":"BF4401783_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/01.WCB.0000067704.86573.83","volume":"23","author":"E Shohami","year":"2003","unstructured":"Shohami E, Yatsiv I, Alexandrovich A, Haklai R, Elad-Sfadia G, Grossman R, Biegon A and Kloog Y (2003) The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model. J. Cereb. Blood Flow Metab. 23: 728\u2013738","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BF4401783_CR42","doi-asserted-by":"publisher","first-page":"22348","DOI":"10.1074\/jbc.M003203200","volume":"275","author":"IM Hussaini","year":"2000","unstructured":"Hussaini IM, Karns LR, Griffith V, Carpenter JE, Redpath GT, Sando JJ and VandenBerg SR (2000) Phorbol 12-myristate-13-acetate induces protein kinase C-\u03b7-specific proliferative response in astrocytic tumor cells. J. Biol. Chem. 275: 22348\u201322354","journal-title":"J. Biol. Chem."},{"key":"BF4401783_CR43","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.1074\/jbc.M409056200","volume":"280","author":"S Amos","year":"2005","unstructured":"Amos S, Martin PM, Polar GA, Parsons SJ and Hussaini IM (2005) Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase C\u03b4\/c-Src pathways in glioblastoma cells. J. Biol. Chem. 280: 7729\u20137738","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/4401783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4401783","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4401783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T05:53:15Z","timestamp":1706680395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4401783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,21]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BF4401783"],"URL":"https:\/\/doi.org\/10.1038\/sj.cdd.4401783","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,21]]}}}